A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2

S Mhatre, S Naik, V Patravale - Computers in biology and medicine, 2021 - Elsevier
Background COVID-19 is an infectious disease caused by a novel positive-sense single-
stranded RNA coronavirus called as SARS-CoV-2. This viral disease is known to infect the …

Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2

A Basu, A Sarkar, U Maulik - Scientific reports, 2020 - nature.com
Abstract Angiotensin converting enzyme 2 (ACE2)(EC: 3.4. 17.23) is a transmembrane
protein which is considered as a receptor for spike protein binding of novel coronavirus …

[HTML][HTML] Identification of dietary molecules as therapeutic agents to combat COVID-19 using molecular docking studies

MF Khan, MA Khan, ZA Khan, T Ahamad, WA Ansari - 2020 - europepmc.org
Recently, a new and fatal strain of coronavirus named as SARS-CoV-2 (Disease: COVID-19)
appeared in Wuhan, China in December of 2019. Due to its fast growing human to human …

[HTML][HTML] In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2

AS Jain, P Sushma, C Dharmashekar… - Saudi Journal of …, 2021 - Elsevier
The novel coronavirus pandemic has spread over in 213 countries as of July 2020.
Approximately 12 million people have been infected so far according to the reports from …

[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

SK Chidambaram, D Ali, S Alarifi… - Journal of Infection and …, 2020 - Elsevier
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …

In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19

V Kumar, S Kancharla, MK Jena - VirusDisease, 2021 - Springer
The recent outbreak of the novel coronavirus (SARS-CoV-2) in the Wuhan province of China
has taken millions of lives worldwide. In this pandemic situation and absence of known …

Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational …

CB Mishra, P Pandey, RD Sharma… - Briefings in …, 2021 - academic.oup.com
The global pandemic crisis, coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has claimed the lives of millions of …

Possible beneficial actions of caffeine in SARS-CoV-2

BS Romero-Martinez, LM Montano… - International Journal of …, 2021 - mdpi.com
The COVID-19 pandemic has established an unparalleled necessity to rapidly find effective
treatments for the illness; unfortunately, no specific treatment has been found yet. As this is a …

Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach

R Rolta, D Salaria, PP Sharma, B Sharma… - Current pharmacology …, 2021 - Springer
COVID-19, the disease caused by SARS-CoV-2, has been declared as a global pandemic.
Traditional medicinal plants have long history to treat viral infections. Our in silico approach …

[HTML][HTML] Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A …

MR Rameshkumar, P Indu, N Arunagirinathan… - Saudi journal of …, 2021 - Elsevier
An outbreak of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has been
recognized as a global health concern. Since, no specific antiviral drug is proven effective …